CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,000,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 14,608 shares at $29.00 ($423,632)
- 4 Grant or award Chief Operating Officer acquired 968 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 684 shares (grant or award)
- 4 Grant or award Head of Research & Development acquired 684 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,256 shares (grant or award)
Page 10 of 18 · 356 filings